Association between plasma vitamin C concentrations and blood pressure in the European prospective investigation into cancer-norfolk population-based study

Hypertension

Volumn 58, Issue 3, 2011, Pages 372-379

  Myint, Phyo K ^a,b,c   Luben, Robert N ^c   Wareham, Nicholas J ^d   Khaw, Kay Tee ^c  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d MRC EPIDEMIOLOGY UNIT   (United Kingdom)

Author keywords

antioxidant; ascorbic acid; Blood pressure; diet; hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FRUIT; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SMOKING; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VEGETABLE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AGE FACTORS; AGED; ASCORBIC ACID; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; EUROPE; FEMALE; GREAT BRITAIN; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS;

EID: 80051923231     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.171108     Document Type: Article

References (35)

1. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part II-variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104:2855-2864. (Pubitemid 33126663)
2. Withworth JA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992.
3. Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L, Neal B, Rodgers A, Ni Mhurchu C, Clark T. 1999 World Health Organization- International Society of Hypertension guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens. 1999;21:1009-1060. (Pubitemid 29325497)
4. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease: part 1-prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774. (Pubitemid 20106689)
5. UK Prospective Diabetes Study Group (UKPDS). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
6. Zanchetti A, Ruilope LM. Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials? J Hypertens. 2002;20:2099-2110. (Pubitemid 35388221)
7. Food Standard Agency. EVM review of vitamin C: eat well, be well-helping you make healthier choices. http://www.food.gov.uk/multimedia/pdfs/evm-c.pdf. Accessed January 15, 2011.
8. Hickey S, Roberts H. Ascorbate: The Science of Vitamin C. Napa, California: Lulu Press, Inc; 2004.
9. Hickey S, Roberts H. Misleading information on the properties of vitamin C. PLoS Med. 2005;2:e307; author reply e309.
10. Finnish ATBC Study. The effect of vitamin E and carotene on the incidence of lung cancer and other cancers in male smokers: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330:1029-1035.
11. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Eng J Med. 2000;342:154-160. (Pubitemid 30051646)
12. Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S, Day N. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study-European Prospective Investigation Into Cancer and Nutrition. Lancet. 2001; 357:657-663. (Pubitemid 32206423)
13. Yokoyama T, Date C, Kokubo Y, Yoshiike N, Matsumura Y, Tanaka H. Serum vitamin C concentration was inversely associated with subsequent 20-year incidence of stroke in a Japanese rural community: the Shibata Study. Stroke. 2000;31:2287-2294.
14. Myint PK, Luben RN, Welch AA, Bingham SA, Wareham NJ, Khaw KT. Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation Into Cancer Norfolk Prospective Population Study. Am J Clin Nutr. 2008;87: 64-69.
15. Day N, Oakes S, Luben R, Khaw KT, Bingham S, Welch A, Wareham N. EPIC-Norfolk: study design and characteristics of the cohort-European Prospective Investigation of Cancer. Br J Cancer. 1999;80:95-103.
16. Vuilleumier J, Keck E. Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. J Micronutr Anal. 1989;5:25-34. (Pubitemid 19033905)
17. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
18. Elias P, Halstead K, Prandy K. CASOC: computer-assisted standard occupational coding. London, United Kingdom: HMSO; 1993.
19. Shohaimi S, Luben R, Wareham N, Day N, Bingham S, Welch A, Oakes S, Khaw KT. Residential area deprivation predicts smoking habit independently of individual educational level and occupational social class: a cross sectional study in the Norfolk Cohort of the European Prospective Investigation Into Cancer (EPIC-Norfolk). J Epidemiol Community Health. 2003;57:270-276. (Pubitemid 36399116)
20. Welch AA, Luben R, Khaw KT, Bingham SA. The CAFE computer program for nutritional analysis of the EPIC-Norfolk food frequency questionnaire and identification of extreme nutrient values. J Hu Nutr Dietet. 2005;18:99-116. (Pubitemid 40514896)
21. Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, Hennings S, Day NE. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Public Health Nutr. 2003;6:407-413. (Pubitemid 36749764)
22. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23-33.
23. Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA. 2006;295:655-666. (Pubitemid 43209067)
24. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, Heinonen OP. Randomised trial of alpha-tocopherol and-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 1997;349:1715-1720. (Pubitemid 27252669)
25. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation withcarotene on the incidence of malignant neoplasms and cardiovascular disease. N Eng J Med. 1996; 334:1145-1149. (Pubitemid 26137972)
26. Levine M, Rumsey SC, Daruwala R, Park JB, Wang Y. Criteria and recommendations for vitamin C intake. JAMA. 1999;281:1415-1423. (Pubitemid 29190220)
27. Langlois MR, Delanghe JR, De Buyzere ML, Bernard DR, Ouyang J. Effect of haptoglobin on the metabolism of vitamin C. Am J Clin Nutr. 1997;66:606-610. (Pubitemid 27366784)
28. Cahill LE, El-Sohemy A. Haptoglobin genotype modifies the association between dietary vitamin C and serum ascorbic acid deficiency. Am J Clin Nutr. 2010;92:1494-1500.
29. Sardi B. High-dose vitamin C and iron overload. Ann Intern Med. 2004; 140:846.
30. Oliveira-Sales EB, Dugaich AP, Carillo BA, Abreu NP, Boim MA, Martins PJ, D'Almeida V, Dolnikoff MS, Bergamaschi CT, Campos RR. Oxidative stress contributes to renovascular hypertension. Am J Hypertens. 2008;21:98-104.
31. Nishi EE, Oliveira-Sales EB, Bergamaschi CT, Oliveira TG, Boim MA, Campos RR. Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in the kidney in Wistar rats. Am J Hypertens. 2010;23:473-480.
32. Buttros JB, Bergamaschi CT, Ribeiro DA, Fracalossi AC, Campos RR. Cardioprotective actions of ascorbic acid during isoproterenol-induced acute myocardial infarction in rats. Pharmacology. 2009;84:29-37.
33. Kelly RP, Poo Yeo K, Isaac HB, Lee CY, Huang SH, Teng L, Halliwell B, Wise SD. Lack of effect of acute oral ingestion of vitamin C on oxidative stress, arterial stiffness or blood pressure in healthy subjects. Free Radic Res. 2008;42:514-522. (Pubitemid 351935165)
34. Block G, Jensen CD, Norkus EP, Hudes M, Crawford PB. Vitamin C in plasma is inversely related to blood pressure and change in blood pressure during the previous year in young Black and White women. Nutr J. 2008;7:35.
35. Rodrigo R, Prat H, Passalacqua W, Araya J, Bächler JP. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clin Sci (Lond). 2008;114:625-634. (Pubitemid 351596387)